3Liang X, Bi S, Yang W, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992 - 2005 in China [ J ]. J Infect Dis, 2009, 200 ( 1 ) : 39 - 47.
4Wang Y, Jia J. Control of hepatitis B in china prevention and treat- ment [ J ]. Expert Rev Anti Infect Ther, 2011, 9 ( 1 ) : 21 - 25.
5Clinical and Laboratory Standards Institute. User protocolfor evalu- ationofqualitativetestpefformance; approvedguideline[ S]. 2nd edi- tion. CLSI, 2008.
6Chu CM, Hung SJ, Lin J, et al. Natural history of hepatitis B anti- gen to antibody in patients with normal serum amin- otransferase levels[J]. Am J Med, 2004, 116(12) : 829 -834.
7HsuYS, Chien RN, Yeh CT, et al. Long - term outcome after spontaneous HbeAg seroconversion inpatients with chronic hepatiti B[J]. Hepatology, 2002, 35(6) : 1522 - 1527.
8Yu DM, Li XH, Mom V, et al. N - Glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape[J]. J Hepatol, 2014, 60(3) : 515 -522.
9Ly D, Yee HF Jr, Brezina M, et al. Hepatitis B surface antigene- mia in chronic hemodialysis patients: effect of hepatitis B immuni- zation[J]. Am J Gastroenterol, 2002, 97( 1 ) : 138 - 141.
10Vanacker A, Vandewiele I, Verbanck J, et al. Transiently positive hepatitis B surface antigen after vaccination with the new hepatitis B vaccineHBV - AS04[J]. Am J Kidney Dis, 2008, 52(5): 1028 - 1029.
